We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Can Intra-tumor Immunotherapy Reduce Side Effects?

News   Oct 24, 2018 | Original story from Houston Methodist

 
Implantable Drug-eluting Nanofluidic Device Delivers Immunotherapy

Smaller than a grain of rice, this tiny device, invented by a Houston Methodist nanoscientist, delivers immunotherapy straight into a tumor, eliminating both side effects and the need for multiple IV treatments. Credit: Houston Methodist

 
 
 

RELATED ARTICLES

Ebola Vaccine Could Stretch Farther

News

A new study has identified that a single dose of a highly diluted Ebola vaccine still fully protected against disease in a monkey model.

READ MORE

Ranitidine Recalled Due to Potential Carcinogen Contamination

News

Teva UK Ltd is recalling unexpired stock of certain batches of two types of Ranitidine medicines – used to treat conditions such as heartburn and stomach ulcers.

READ MORE

International Alliance Aims To Detect the (Almost) Undetectable

News

A new transatlantic research alliance aims to develop radical new strategies and technologies to detect cancer at its earliest stage.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE